The Active Pharmaceutical Ingredient Industry is the organ by which active pharmaceutical ingredients are manufactured from raw materials through both chemical and physical means. Depending on the complexity of the molecule required, synthesis of APIs might need multi-step complex chemistry utilizing a range of processing technologies.
Dynarx Specializes in a range of API-related fields and works in areas such as chemical synthesis, fermentation, chromatography and plant extraction.
Chemical synthesis for small molecule manufacturing is one of Dynarx’ key competencies.As a well-rounded custom manufacturer, we embrace the current market excitement of Fluorine Chemistry in pharmaceuticals while leveraging and innovating advanced chemical synthesis to adopt a broad, balanced portfolio of technologies.
Semi-synthesis is a type of a chemical synthesis that utilizes compounds isolated from natural sources as starting material, such as bacterial or cell cultures or plant material. These natural biomolecules are usually large and complex. Generally, semi-synthetic derivatives outperform original biomolecules with respect to potency, stability or safety.
To improve the environmental profile of our manufacturing processes and end products, Dynarx devices innovative means to increase reaction efficiency and yield in order to reduce waste, reduce solvents and reagents while synthesizing active pharmaceutical ingredients,